The peripheral and central role of the catecholamines in the mechanisms of anxiety.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D001008:Anxiety Disorders / Q000503:physiopathology; D001143:Arousal; D001569:Benzodiazepines; D001921:Brain / Q000503:physiopathology; D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology*; D002552:Cerebral Ventricles / Q000378:metabolism; D003071:Cognition; D006801:Humans; D008954:Models, Biological; D011433:Propranolol / Q000627:therapeutic use; D013312:Stress, Physiological / Q000150:complications; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D002395:Catecholamines; D013565:Sympatholytics; D013566:Sympathomimetics; D001569:Benzodiazepines; D011433:Propranolol